Others use a GLP-1 maintenance dose long-term
Injection site reactions, including erythema, pruritus, and nodule formation (particularly with extended-release formulations), occur in approximately 10-20% of patients
check the NIHR 'Be Part of Research' portal or ClinicalTrials.gov for current recruiting studies
A., Nguyen H., Wittbrodt E
Note: Ozempic , Mounjaro , Victoza , and metformin are not FDA-approved to treat obesity or for weight loss
Common symptoms include: Sudden, unexplained shakiness or tremors Excessive sweating or cold sweats Dizziness or feeling faint Rapid heartbeat or palpitations Intense hunger (even if you recently ate) Irritability or sudden mood changes Blurred vision or brain fog If you experience these symptoms, it is vital to consume a fast-acting source of glucose, such as a small glass of fruit juice or glucose tabs, and contact your healthcare provider immediately